About
Technology
Issues
FAQ
Links
Official Page
278MO cfDNA analysis from phase I/II study of lerociclib (G1T38), a continuously dosed oral CDK4/6 inhibitor, with fulvestrant in HR+/HER2- advanced breast cancer patients
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.